Skip to content

ALPHAMEDIS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ALPHAMEDIS

BE 0456.605.328
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 against 2026filed annual accounts (NBB)
Net result for the year
-€424,537
2025 · -€482,638+€58,101
Equity
€951,661
2025 · €1.4m-€424,537
Cash
€489,398
2025 · €508,479-€19,081
Balance sheet total
€2.2m
2025 · €2.2m-€45,645

Largest movements

2025 to 2026
Assets
  • Receivables within one year -€34,444

    down €34,444 (-3.2%), from €1.1m to €1.1m

    of which Trade receivables: -€34,089

Equity and liabilities
  • Profit (loss) carried forward -€424,537

    down €424,537 (-36.7%), from €1.2m to €732,311

  • Trade debts +€278,107

    up €278,107 (+51.6%), from €538,806 to €816,913

  • Other debts +€100,000

    new in 2026: €100,000

Income statement
  • Gross operating margin -€348,782

    down €348,782 (-20.7%), from €1.7m to €1.3m

  • Staff costs -€269,771

    down €269,771 (-13.7%), from €2.0m to €1.7m

  • Other operating charges -€114,996

    down €114,996 (-79.1%), from €145,369 to €30,373

  • Provisions -€17,459

    down €17,459 (-92.9%), from €18,803 to €1,344

From the 2025 result to the 2026 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2025 -€482,638
Gross operating margin -€348,782
Staff costs +€269,771
Depreciation +€4,329
Write-downs +€4,710
Provisions +€17,459
Other operating charges +€114,996
Financial income +€20
Financial charges -€4,314
Taxes -€88
Result 2026 -€424,537

Cash bridge derived

cash 2025 to 2026

Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€9,183
Investment -€28,264
Financing €0
Cash 2025 €508,479
Net result for the year -€424,537
Depreciation +€18,858
Stocks and contracts -€8,979
Receivables within one year +€34,444
Deferred charges and accrued income +€10,505
Provisions +€1,344
Trade debts +€278,107
Tax, wage and social debts -€6,647
Other debts +€100,000
Accrued charges and deferred income +€6,087
Investment in fixed assets (net) -€28,264
Cash 2026 €489,398
Every line side by side 54 lines
Line Code 2025 2026 Change %
Total assets 20/58 €2,203,917 €2,158,272 -€45,645 -2.1%
Fixed assets 21/28 €43,511 €52,917 +€9,406 +21.6%
Tangible fixed assets 22/27 €27,461 €36,867 +€9,406 +34.3%
Plant, machinery and equipment 23 €12,312 €19,292 +€6,980 +56.7%
Furniture and vehicles 24 €9,310 €15,916 +€6,606 +71.0%
Other tangible fixed assets 26 €5,838 €1,659 -€4,179 -71.6%
Financial fixed assets 28 €16,050 €16,050 = 0.0%
Current assets 29/58 €2,160,406 €2,105,355 -€55,051 -2.5%
Stocks and contracts in progress 3 €538,130 €547,108 +€8,979 +1.7%
Stocks 30/36 €538,130 €547,108 +€8,979 +1.7%
Amounts receivable within one year 40/41 €1,091,464 €1,057,020 -€34,444 -3.2%
Trade receivables 40 €1,090,797 €1,056,708 -€34,089 -3.1%
Other amounts receivable 41 €667 €312 -€354 -53.1%
Cash at bank and in hand 54/58 €508,479 €489,398 -€19,081 -3.8%
Deferred charges and accrued income 490/1 €22,333 €11,828 -€10,505 -47.0%
Total equity and liabilities 10/49 €2,203,917 €2,158,272 -€45,645 -2.1%
Equity 10/15 €1,376,198 €951,661 -€424,537 -30.8%
Contributions 10/11 €124,000 €124,000 = 0.0%
Capital 10 €124,000 €124,000 = 0.0%
Issued capital 100 €124,000 €124,000 = 0.0%
Reserves 13 €95,350 €95,350 = 0.0%
Non-distributable reserves 130/1 €14,938 €14,938 = 0.0%
Legal reserve 130 €14,938 €14,938 = 0.0%
Tax-exempt reserves 132 €37,500 €37,500 = 0.0%
Distributable reserves 133 €42,912 €42,912 = 0.0%
Profit (loss) carried forward 14 €1,156,848 €732,311 -€424,537 -36.7%
Provisions and deferred taxes 16 €18,803 €20,147 +€1,344 +7.1%
Provisions for liabilities and charges 160/5 €18,803 €20,147 +€1,344 +7.1%
Pensions and similar obligations 160 €18,803 €20,147 +€1,344 +7.1%
Amounts payable 17/49 €808,916 €1,186,464 +€377,548 +46.7%
Amounts payable within one year 42/48 €776,949 €1,148,409 +€371,460 +47.8%
Trade debts 44 €538,806 €816,913 +€278,107 +51.6%
Suppliers 440/4 €538,806 €816,913 +€278,107 +51.6%
Taxes, remuneration and social security 45 €238,143 €231,497 -€6,647 -2.8%
Taxes 450/3 €3,475 €11,185 +€7,709 +221.8%
Remuneration and social security 454/9 €234,668 €220,312 -€14,356 -6.1%
Other amounts payable 47/48 - €100,000 +€100,000
Accrued charges and deferred income 492/3 €31,967 €38,054 +€6,087 +19.0%
Non-recurring operating income 76A €0 - =
Remuneration, social security and pensions 62 €1,967,106 €1,697,334 -€269,771 -13.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,187 €18,858 -€4,329 -18.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€5,743 -€10,453 -€4,710 -82.0%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 €18,803 €1,344 -€17,459 -92.9%
Other operating charges 640/8 €145,369 €30,373 -€114,996 -79.1%
Gross operating margin 9900 €1,685,937 €1,337,155 -€348,782 -20.7%
Operating profit (loss) 9901 -€462,784 -€400,302 +€62,482 +13.5%
Financial income 75/76B €437 €457 +€20 +4.5%
Recurring financial income 75 €437 €457 +€20 +4.5%
Financial charges 65/66B €16,029 €20,342 +€4,314 +26.9%
Recurring financial charges 65 €16,029 €20,342 +€4,314 +26.9%
Profit (loss) for the period before taxes 9903 -€478,376 -€420,187 +€58,189 +12.2%
Income taxes 67/77 €4,262 €4,350 +€88 +2.1%
Profit (loss) for the period 9904 -€482,638 -€424,537 +€58,101 +12.0%
Profit (loss) for the period to be appropriated 9905 -€482,638 -€424,537 +€58,101 +12.0%

Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.